search

menu

  • Research Research
    • Where science meets inspired minds

    • Back
    • Research
    • Our Science
    • Research Groups
    • Facilities & Platforms
    • Clinical research
    • Find a researcher
    • Publications
    • Knowledge Transfer
  • Careers & study Careers & study
    • Become a leader in cancer research

    • Back
    • Careers & study
    • Vacancies
    • Faculty
    • Scientific staff
    • Scientific support staff
    • Postdoctoral fellows
    • PhD Students
    • Operational staff
    • Clinical fellows
    • Life in Amsterdam
    • Student internships
  • News & Events News & Events
    • Check out our stories and events

    • Back
    • News & Events
    • News
    • Media & Press
    • Calendar
  • About us About us
    • Maximum impact for cancer patients

    • Back
    • About us
    • Our vision
    • Organization
    • Collaborations
    • Responsible Research
    • Support us
    • Visit us
    • Contact us
  • Support us
Support us
  • Home
  • Publications
  • Research
  • Publications
  • Article

A specific form of cPRC1 containing CBX4 is co-opted to mediate oncogenic gene repression in diffuse midline glioma.

Eimear Lagan ,
Dáire Gannon ,
Ademar Jesus Silva ,
Peter Bibawi ,
Anthony M Doherty ,
Darragh Nimmo ,
Rachel McCole ,
Craig Monger ,
Giovani Luiz Genesi ,
Aurelie Vanderlinden ,
James A Innes ,
Charlotte L E Jones ,
Lu Yang ,
Bryan Chen ,
Guido van Mierlo ,
Pascal W T C Jansen ,
Chinmayi Pednekar ,
Alexander Von Kriegsheim ,
Kieran Wynne ,
Francisco J Sánchez-Rivera ,
Yadira M Soto-Feliciano ,
Angel M Carcaboso ,
Michiel Vermeulen ,
Giorgio Oliviero ,
Chun-Wei Chen ,
Richard E Phillips ,
Adrian P Bracken ,
Gerard L Brien

Abstract

Diffuse midline glioma (DMG) is a fatal childhood brain tumor characterized primarily by mutant histone H3 (H3K27M). H3K27M causes a global reduction in Polycomb repressive complex 2 (PRC2)-mediated H3K27 trimethylation (H3K27me3). Paradoxically, PRC2 is essential in DMG cells, although the downstream molecular mechanisms are poorly understood. Here, we have discovered a specific form of canonical PRC1 (cPRC1) containing CBX4 and PCGF4 that drives oncogenic gene repression downstream of H3K27me3 in DMG cells. Via a novel functional region, CBX4 preferentially associates with PCGF4-containing cPRC1. The characteristic H3K27me3 landscape in DMG rewires the distribution of cPRC1 complexes, with CBX4/PCGF4-cPRC1 accumulating at H3K27me3-enriched CpG islands. Despite comprising <5% of cPRC1 in DMG cells, the unique repressive functions of CBX4/PCGF4-cPRC1 are essential for DMG growth. Our findings link the altered distribution of H3K27me3 to imbalanced cPRC1 function, which drives oncogenic gene repression in DMG, highlighting potential therapeutic opportunities for this incurable childhood brain cancer.

More about this publication

Molecular cell

Volume 85
Issue nr. 11
Pages 2110-2127.e7
Publication date 05-06-2025

Full text links

Publisher website (DOI) 10.1016/j.molcel.2025.04.026
Europe PubMed Central 40403727
Pubmed 40403727

Where science meets inspired minds

Contact

Plesmanlaan 121
1066CX Amsterdam

020 512 9111 communicatie@nki.nl

Quick links

  • Vacancies
  • News
  • Contact us
  • Media & Press

Follow us on

Disclaimer
Privacy statement
Cookies
Change cookie settings

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.